Esmat Habib Ahmad, Naseri Mohammad Wali
Department of Radiology, Kabul University of Medical Sciences, Kabul, Afghanistan.
Department of Internal Medicine, Division of Endocrinology, Metabolism, and Diabetes, Kabul University of Medical Sciences, Kabul, Afghanistan.
Ann Med Surg (Lond). 2021 Feb 1;62:477-480. doi: 10.1016/j.amsu.2021.01.090. eCollection 2021 Feb.
Aortocaval fistulas (ACFs) are a rare complication of abdominal aortic aneurysm (AAA), associated with high morbidity and mortality. It is thought that increased tension in the walls of large aneurysms can cause an inflammatory reaction resulting in adhesion to the adjacent vein and culminating in necrosis of the adherent layers and fistula formation.
A 70-year-old male was referred from a local state center to the emergency department of our hospital, complaining of weakness and oliguria for two days. The laboratory analysis yielded high urea and creatinine levels, indicating an acute renal failure. Computed tomography images showed an aortocaval fistula complicating infrarenal abdominal aortic aneurysm. The patient was successfully managed with endovascular intervention.
Aortocaval fistulas generally affect elderly men with an average age of 65 years. The diagnosis is often delayed because of the variable clinical manifestations, which increases the difficulties in treatment. Conventional surgical intervention has high mortality rates. However, endoleaks and paradoxical pulmonary embolism are the main concerning complications of endovascular treatment.
Spontaneous aortocaval fistulas are a rare, but potentially life-threatening complication of abdominal aortic aneurysm with myriad clinical manifestations. Early diagnosis and management can directly affect the prognosis and outcome. Modern non-invasive diagnostic imaging can help timely diagnosis and provide a road map for the treatment plan. Endovascular repair is the first choice of treatment. However, a high incidence and persistence of endoleak with the endovascular approach requires caution and a close long time follow up.
主动脉腔静脉瘘(ACF)是腹主动脉瘤(AAA)的一种罕见并发症,与高发病率和死亡率相关。据认为,大型动脉瘤壁张力增加可引发炎症反应,导致与相邻静脉粘连,最终导致粘连层坏死并形成瘘管。
一名70岁男性从当地州立中心转诊至我院急诊科,主诉两天来乏力和少尿。实验室分析显示尿素和肌酐水平升高,提示急性肾衰竭。计算机断层扫描图像显示肾下腹主动脉瘤合并主动脉腔静脉瘘。该患者通过血管内介入治疗成功治愈。
主动脉腔静脉瘘通常影响平均年龄为65岁的老年男性。由于临床表现多样,诊断往往延迟,这增加了治疗难度。传统手术干预死亡率高。然而,内漏和矛盾性肺栓塞是血管内治疗的主要相关并发症。
自发性主动脉腔静脉瘘是腹主动脉瘤一种罕见但可能危及生命的并发症,临床表现多样。早期诊断和治疗可直接影响预后和结局。现代无创诊断成像有助于及时诊断并为治疗方案提供路线图。血管内修复是首选治疗方法。然而,血管内治疗内漏的高发生率和持续性需要谨慎并进行长期密切随访。